Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2) Peptid
BSCL2
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle BSCL2 Produkte
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- QEESTPQSDV TEDGESPEDP SGTEGQLSEE EKPDQQPLSG EEELEPEAS
- Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of BSCL2 antibody, catalog no. 70R-8856
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
- Target
- BSCL2 (Berardinelli-Seip Congenital Lipodystrophy 2 (Seipin) (BSCL2))
- Synonyme
- GNG3LG Peptide, HMN5 Peptide, SPG17 Peptide, 2900097C17Rik Peptide, AI046355 Peptide, Gng3lg Peptide, BSCL2, seipin lipid droplet biogenesis associated Peptide, Berardinelli-Seip congenital lipodystrophy 2 (seipin) Peptide, BSCL2 Peptide, Bscl2 Peptide
-
Sie sind hier:
